[ Price : $8.95]
A legal update from Wilson Sonsini Goodrich & Rosati addresses FDAs release earlier this month of a draft guidance clarifying the ...[ Price : $8.95]
FDA grants a priority review to an Ionis Pharmaceuticals NDA for zilganersen, an experimental treatment for Alexander disease.[ Price : $8.95]
A new study published in JAMA Network Open highlights growing public health concerns over prescription drug promotion by social me...[ Price : $8.95]
The International Council for Harmonization outlines a roadmap for future global standards on advanced drug manufacturing, highlig...[ Price : $8.95]
FDA hosts a public meeting next month aimed at exploring ways to expand access to nonprescription medications.[ Price : $8.95]
U.S. Senator Rick Scott (R-FL) urges FDA and other federal health agencies to review and tighten oversight of clinical trials and ...[ Price : $8.95]
FDA approves Bristol Myers Squibbs Opdivo (nivolumab) for use with doxorubicin, vinblastine, and dacarbazine for adult and pediatr...[ Price : $8.95]
FDA is announcing a 6/12 public hearing to gather input on its Commissioners National Priority Voucher Pilot Program.